Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2026-04-18 @ 1:45 PM
Study NCT ID:
NCT01302392
Status:
COMPLETED
Last Update Posted:
2017-05-02
First Post:
2011-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PX-171-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None